Latest News

Galux pushes AI protein design toward bigger global pharma deals
Read More
From Seoul to the Global Stage: Reimagining Antibody Discovery with AI
Read More
Galux claims ‘one-day antibody design’ as it enters the global top-three AI race
Read More
Pioneering Precision: How South Korea's Galux is Redefining Antibody Discovery with AI
Read More
[Interview] DeepMind predicted proteins. A Korean startup says it's designing the future of antibodies.
Read More
Korean AI firm Galux develops six novel therapeutic antibodies using innovative design methods
Read More